ReviewCancers2022

Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario.

Calogera Claudia Spagnolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.